Clinical trial
Efficacy of Self-assembling Peptide P11-4 for the Treatment of Orthodontically Induced Initial Carious Lesions: a Randomized Clinical Trial
NCT06749977 is registered in ClinicalTrials.gov with Medical University of Sofia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Self-assembling Peptide P11-4 for the Treatment of Orthodontically Induced Initial Carious Lesions: a Randomized Clinical Trial
- Lead sponsor
- Medical University of Sofia
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 1, 2020
- Completion date
- February 20, 2023
- Enrollment
- 45 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
white spot lesions